Skip to main content


Fig. 2 | Radiation Oncology

Fig. 2

From: Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients

Fig. 2

Kaplan-Meier curve of the (a) DXM use concurrent with RT was a poor prognostic indicator of OS in patients receiving TMZ (12.7 vs 22.6 months, p = 0.003 by log-rank test). b DXM use was a poor prognostic factor for OS in patients who underwent a GTR treated with TMZ alone (13.5 vs 25.1 months, p = 0.01 by log-rank test). c DXM did not reduce OS patients who received TMZ and BEV concurrent with RT (22.9 vs 22.8 months, p = 0.4818 by log-rank test)

Back to article page